Uremic toxins, such as indoxyl sulfate (IS), p-cresyl sulfate (PCS), transforming growth factor-beta (TGF-β), and advanced glycation end-products (AGEs), are considered potential risk factors in various CKD-related conditions, including bone and joint metabolism [13,14,15]. This evidence concerns the gene TGFB1 and chronic kidney disease.